Australia markets close in 5 minutes

Aarti Drugs Limited (AARTIDRUGS.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
521.20+0.05 (+0.01%)
As of 11:22AM IST. Market open.
Currency in INR

Valuation measures4

Market cap (intra-day) 47.91B
Enterprise value 53.35B
Trailing P/E 28.08
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.89
Price/book (mrq)3.74
Enterprise value/revenue 2.11
Enterprise value/EBITDA 16.64

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 317.44%
S&P500 52-week change 325.87%
52-week high 3624.00
52-week low 3430.00
50-day moving average 3494.68
200-day moving average 3505.92

Share statistics

Avg vol (3-month) 314.65k
Avg vol (10-day) 315.71k
Shares outstanding 591.94M
Implied shares outstanding 692.08M
Float 833.67M
% held by insiders 161.94%
% held by institutions 16.48%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41
Forward annual dividend yield 40.19%
Trailing annual dividend rate 31.00
Trailing annual dividend yield 30.19%
5-year average dividend yield 42.33
Payout ratio 45.39%
Dividend date 3N/A
Ex-dividend date 406 Feb 2024
Last split factor 24:1
Last split date 330 Sept 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 6.78%
Operating margin (ttm)11.82%

Management effectiveness

Return on assets (ttm)6.93%
Return on equity (ttm)13.87%

Income statement

Revenue (ttm)25.29B
Revenue per share (ttm)275.02
Quarterly revenue growth (yoy)-16.50%
Gross profit (ttm)N/A
EBITDA 3.2B
Net income avi to common (ttm)1.71B
Diluted EPS (ttm)18.55
Quarterly earnings growth (yoy)-15.50%

Balance sheet

Total cash (mrq)207.7M
Total cash per share (mrq)2.26
Total debt (mrq)5.64B
Total debt/equity (mrq)44.02%
Current ratio (mrq)1.66
Book value per share (mrq)139.39

Cash flow statement

Operating cash flow (ttm)3.59B
Levered free cash flow (ttm)1.22B